PANCREATIC DUCTAL ADENOCARCINOMA (PDAC)
Clinical trials for PANCREATIC DUCTAL ADENOCARCINOMA (PDAC) explained in plain language.
Never miss a new study
Get alerted when new PANCREATIC DUCTAL ADENOCARCINOMA (PDAC) trials appear
Sign up with your email to follow new studies for PANCREATIC DUCTAL ADENOCARCINOMA (PDAC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New antibody combo shows promise against hard-to-treat cancers
Disease control OngoingThis early-phase trial tests an experimental antibody called GEN1042, alone or with the cancer drug pembrolizumab (with or without chemotherapy), in adults with advanced solid tumors like lung, colon, melanoma, head and neck, or pancreatic cancer. The main goals are to check safe…
Matched conditions: PANCREATIC DUCTAL ADENOCARCINOMA (PDAC)
Phase: PHASE1, PHASE2 • Sponsor: Genmab • Aim: Disease control
Last updated Jun 12, 2026 12:03 UTC
-
New hope for tough pancreatic cancer? drug combo enters early trial
Disease control OngoingThis early-phase study tests a combination of two drugs, HRS-4642 and nimotuzumab, in 20 people with pancreatic cancer that has come back or spread. The main goals are to find the safest dose and see if the treatment shrinks tumors. Participants must have measurable tumors and be…
Matched conditions: PANCREATIC DUCTAL ADENOCARCINOMA (PDAC)
Phase: PHASE1, PHASE2 • Sponsor: West China Hospital • Aim: Disease control
Last updated Jun 11, 2026 12:10 UTC
-
New drug M9140 targets Hard-to-Treat cancers in early trial
Disease control OngoingThis study tests an experimental drug called M9140 in people with advanced solid tumors (stomach, lung, or pancreatic cancer) that have a specific protein called CEACAM5. The drug is designed to deliver a powerful chemotherapy directly to cancer cells, aiming to shrink tumors whi…
Matched conditions: PANCREATIC DUCTAL ADENOCARCINOMA (PDAC)
Phase: PHASE1, PHASE2 • Sponsor: EMD Serono Research & Development Institute, Inc. • Aim: Disease control
Last updated Jun 08, 2026 13:09 UTC
-
Pancreatic cancer study tracks early relapse after surgery
Knowledge-focused ENROLLING_BY_INVITATIONThis study watches 500 adults who had surgery to remove pancreatic cancer, to see how often the cancer comes back within the first year. Researchers will track where it returns (like the liver or lungs) and how it's detected, using routine scans and blood tests. No new treatments…
Matched conditions: PANCREATIC DUCTAL ADENOCARCINOMA (PDAC)
Sponsor: Azienda Ospedaliera di Padova • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:03 UTC
-
New models aim to forecast pancreatic cancer outcomes
Knowledge-focused ENROLLING_BY_INVITATIONThis study aims to create computer models that predict how long patients with advanced pancreatic cancer might live and how well they respond to chemotherapy. Researchers will use medical images, tissue samples, and genetic data from 100 patients. The goal is to help doctors make…
Matched conditions: PANCREATIC DUCTAL ADENOCARCINOMA (PDAC)
Sponsor: RenJi Hospital • Aim: Knowledge-focused
Last updated Jun 15, 2026 18:56 UTC